Literature DB >> 14484317

Resistance to 6-mercaptopurine. I. Biochemical differences between the Ehrlich ascites carcinoma and a 6-mercaptopurine-resistant subline.

A R PATERSON, A HORI.   

Abstract

Entities:  

Keywords:  MERCAPTOPURINE/pharmacology; NEOPLASMS/metabolism; NUCLEOSIDES AND NUCLEOTIDES/metabolism

Mesh:

Substances:

Year:  1962        PMID: 14484317

Source DB:  PubMed          Journal:  Can J Biochem Physiol


× No keyword cloud information.
  3 in total

1.  INHIBITION OF INOSINE 5'-PHOSPHATE DEHYDROGENASE FROM EHRLICH ASCITES-TUMOUR CELLS BY 6-THIONINOSINE 5'-PHOSPHATE.

Authors:  M R ATKINSON; R K MORTON; A W MURRAY
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Inhibition of purine phosphoribosyltransferases from Ehrlich ascites-tumour cells by purine nucleotides.

Authors:  A W Murray
Journal:  Biochem J       Date:  1966-09       Impact factor: 3.857

3.  INHIBITION BY 6-MERCAPTOPURINE OF PURINE PHOSPHORIBOSYLTRANSFERASES FROM EHRLICH ASCITES-TUMOUR CELLS THAT ARE RESISTANT TO THE DRUG.

Authors:  M R ATKINSON; A W MURRAY
Journal:  Biochem J       Date:  1965-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.